Concerning the interaction with seed genes, we confirmed that interleukin/protein kinase/TNF-alpha inhibitors, drugs for musculoskeletal system disorders, TUDCA, immunosuppressants, antirheumatic agents, and simvastatin and atorvastatin were among the potential drug classes, regardless of PBC stage. This evidence concerns the gene WEE1 and musculoskeletal system disorder.